NCT06655597进行中（未招募）4 期
A 12-week Randomized, Controlled, Clinical Trial Evaluating the Efficacy of a Dietary Supplement Powder Formula (Daily Ultimate Essentials) in an Adult Population.
Prenetics Global2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年10月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Body Morphology
研究概览
简要总结
Healthy Adult subjects
详细描述
The study will be a prospective randomized, controlled clinical study. There will be interventional treatment for a total of 12 weeks. The subjects will attend two appointments in the clinic throughout the duration of the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •BMI between 18.5 and 30 kg/m2
- •Low, moderate, and high activity (self-identified) *
- •Self-identify as having fatigue, and abdominal issues (bloating, constipation etc.) *
- •Participants will be able to read, understand and sign an informed consent form (includes HIPAA and States requirements) and sign a photo release form.
- •Participants are willing and able to follow all study directions, attend study visits as scheduled and must be willing to accept the restrictions of the study including but not limited to:
- •Willing to refrain from introducing any new diets or dietary supplements for the duration of the study
排除标准
- 未提供
研究组 & 干预措施
Reds Powder
Experimental
Reds Powder
干预措施: REDS Powder (Dietary Supplement)
Standard
No Intervention
Usual Diet
结局指标
主要结局
Body Morphology
时间窗: 12 weeks
Subjects assessed through weight and height which will be combined to determine BMI and abdominal and thigh circumference and images before and after
次要结局
- Safety and Tolerability(12 weeks)
- Energy(12 weeks)
- Changes in Micronutrient blood levels(12 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2Endocrine System DiseasesNutritional and Metabolic DiseasesDiabetes MellitusNCT00672386Johnson & Johnson Pharmaceutical Research & Development, L.L.C.352
招募中
不适用
Methotrexate vs Azathioprine in Atopic Dermatitis: A 5 year follow up study.atopic dermatitsNL-OMON24759Academic Medical Center, department of Dermatology42
已完成
3 期
Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)Pulmonary Disease, Chronic ObstructiveNCT02006732Boehringer Ingelheim809
已完成
3 期
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)Pulmonary Disease, Chronic ObstructiveNCT01964352Boehringer Ingelheim813
进行中（未招募）
不适用
A 12-week treatment, randomized, double-blind, parallel group, multicenter study to evaluate the efficacy of the valsartan/simvastatin combinations 160/20mg up titrated to 320/20mg versus 160/40mg up titrated to 320/40mg in patients with both essential hypertension and hypercholesterolemiaEssential hypertension and hypercholesterolemiaEUCTR2005-002382-36-DEovartis Pharma Services AG796